Summary
Definition
History and exam
Key diagnostic factors
- history of acute rheumatic fever (ARF) during childhood
- dyspnoea
- elevated jugular venous pressure with prominent a-wave
- low-frequency pre-systolic (diastolic) murmur at lower left sternal border
Other diagnostic factors
- age: 20-39 years
- exercise intolerance
- fatigue
- jugular pulsations
- abdominal swelling and discomfort
- oedema
- cyanosis or hypoxaemia
- atrial fibrillation
- hepatomegaly
- ascites, oedema, anasarca
- age: infancy or childhood
- episodic facial flushing, watery diarrhoea, or bronchoconstriction
- absent right ventricular lift or heave
- opening snap
- endocarditis stigmata (e.g., splinter haemorrhages, Osler nodes, Janeway lesions)
Risk factors
- group A streptococcal (GAS) pharyngitis
- metastatic carcinoid tumours
- artificial tricuspid valve
- intravenous drug use
- pacemaker/defibrillator leads crossing tricuspid valve orifice
- genetic predisposition and environmental factors
Diagnostic investigations
1st investigations to order
- ECG
- chest x-ray
- 2D transthoracic echocardiogram
- Doppler transthoracic echocardiogram
- liver function tests
- blood biochemistry
- FBC
- blood cultures
- 24-hour urinary excretion of 5-hydroxy-indole acetic acid (5-HIAA)
Investigations to consider
- cardiac catheterisation
- cardiac MRI
- 3D transthoracic echocardiogram
- cardiac CT angiography (CTA)
- [18F] fluorodeoxyglucose (FDG)-PET/CT
Treatment algorithm
congenital
with carcinoid heart disease
with rheumatic fever sequelae
with infective endocarditis
Contributors
Authors
John R. Charpie, MD, PhD
Professor
Pediatrics and Communicable Diseases
Division Director
Pediatric Cardiology
Medical Director
Pediatric Cardiothoracic ICU
University of Michigan Congenital Heart Center
Ann Arbor
MI
Disclosures
JRC declares that he has no competing interests.
Jeffrey D. Zampi, MD
Associate Professor
Pediatrics and Communicable Diseases
Director, Interventional Pediatric Cardiology
University of Michigan Congenital Heart Center
Ann Arbor
MI
Disclosures
JZ is a consultant for Medtronic Inc and Gore Medical. JZ serves on the data safety monitoring board for a clinical trial sponsored by Encore Medical. JZ has served as medical expert for several legal cases.
Amanda D. McCormick MD, null
Assistant Professor
Pediatrics and Communicable Diseases
University of Michigan Congenital Heart Center
Ann Arbor
MI
Disclosures
ADM receives grant funding from the NIH.
Acknowledgements
Dr John R. Charpie, Dr Jeffrey D. Zampi, and Dr Amanda D. McCormick would like to gratefully acknowledge Dr Martin L. Bocks, a previous contributor to this topic.
Disclosures
MLB declares that he has no competing interests.
Peer reviewers
Lokesh Tejwani, MD, FACC
Assistant Professor of Clinical Medicine
University of Missouri Hospitals and Clinics
Harry S. Truman VA Hospital
Columbia
MO
Disclosures
LT declares that he has no competing interests.
John Coltart, MD, FRCP, FACC, FESC, MRCS
Consultant Cardiologist
Cardio-thoracic Unit
Guy's and St Thomas' Hospital
London
UK
Disclosures
JC declares that he has no competing interests.
Differentials
- Cardiac tumours
- Systemic lupus erythematosus (SLE)
- Constrictive pericarditis (CP)
More DifferentialsGuidelines
- The tricuspid valve: a review of pathology, imaging and current treatment options: a scientific statement from the American Heart Association
- 2023 ESC guidelines for the management of endocarditis
More Guidelines
Log in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer